Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
2R01DA002163-13
Application #
3207146
Study Section
Drug Abuse Biomedical Research Review Committee (DABR)
Project Start
1978-04-01
Project End
1996-03-31
Budget Start
1991-04-01
Budget End
1992-03-31
Support Year
13
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Texas Health Science Center Houston
Department
Type
Schools of Medicine
DUNS #
City
Houston
State
TX
Country
United States
Zip Code
77225
Bihm, C C; Williams, C L; Burks, T F (1998) Central actions of endomorphins: new endogenous opioids. Proc West Pharmacol Soc 41:81-3
Williams, C L; Rosenfeld, G C; Burks, T F (1997) Cholecystokinin-induced antinociception is not blocked by CCK-A or CCK-B receptor antagonists. Peptides 18:409-14
Shannon, M H; Bihm, C C; Short, W J et al. (1997) Interactions of oxytocin and vasopressin with CRF on the rat colon. Neuropeptides 31:94-8
Williams, C L; Bihm, C C; Rosenfeld, G C et al. (1997) Morphine tolerance and dependence in the rat intestine in vivo. J Pharmacol Exp Ther 280:656-63
Roerig, S C; Williams, C L; Hruby, V J et al. (1996) Inhibition of adenylyl cyclase activity by the cholecystokinin analog SNF 9007 in neuroblastoma x glioma NG108-15 hybrid cells. Regul Pept 61:51-6
Williams, C L; Cody, S; Burks, T F (1994) Stress-induced changes in gastrointestinal transit in mice are dependent on gender. Proc West Pharmacol Soc 37:73-6
Williams, C L; Rosenfeld, G C; Dafny, N et al. (1994) SNF9007: a novel analgesic that acts simultaneously at delta 1, delta 2 and mu opioid receptors. J Pharmacol Exp Ther 269:750-5
Kramer, T H; Davis, P; Hruby, V J et al. (1993) In vitro potency, affinity and agonist efficacy of highly selective delta opioid receptor ligands. J Pharmacol Exp Ther 266:577-84
Lemcke, P K; Shook, J E; Burks, T F (1991) Spinally mediated opioid antidiarrheal effects. Eur J Pharmacol 193:109-15
Weber, S J; Greene, D L; Sharma, S D et al. (1991) Distribution and analgesia of [3H][D-Pen2, D-Pen5]enkephalin and two halogenated analogs after intravenous administration. J Pharmacol Exp Ther 259:1109-17

Showing the most recent 10 out of 79 publications